Sunil Srivastava is an Ophthalmology physician affiliated with Cleveland Clinic. OpenAlex indexes 32 publications with 1,013 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Mail Code I32
Cleveland, OH 441950001
Telephone
216-636-2286Registry record last updated 7 Nov 2011.
Clinical trials
- Vascular Lab Resource (VLR) Biorepository
Sponsor: The Cleveland Clinic
- Imaging Quantification of Inflammation (IQI)
Sponsor: The Cleveland Clinic
- Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant
Sponsor: The Cleveland Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bausch & Lomb Americas Inc.Program year202516 payments$21,330openpaymentsdata.cms.gov ↗
- Ocular Therapeutix, Inc.Program year20251 payment
- Regeneron Pharmaceuticals, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
67.3%Corticosteroid28.4%Prednisolone Acetate100%Part D≥116 patientsCarbonic Anhydrase Inhibitor13.4%Dorzolamide-Timolol100%Part D≥50 patients+ 3 more classes in this area
Metabolism & gastrointestinal
12.4%Corticosteroid11%Prednisone100%Part D≥43 patientsAnticholinergic1.4%Atropine Sulfate100%Part D<11 patientsCardiovascular
9.2%Beta blocker9.2%Timolol Maleate100%Part D≥27 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1999–2000 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Phacoemulsification on Vitreomacular Traction Release and Complications
American Journal of Ophthalmology
2025 - Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular Edema
Journal of VitreoRetinal Diseases
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”